Literature DB >> 32454695

Enhancement of Dissolution of Fenofibrate Using Complexation with Hydroxy Propyl β-Cyclodextrin.

Sachin K Jagdale1, Mohammad H Dehghan2, Nilesh S Paul3.   

Abstract

OBJECTIVES: The aim of the present study was to enhance the dissolution rate of fenofibrate using complexation with hydroxy propyl β-cyclodextrin (HPβCD).
MATERIALS AND METHODS: The phase solubility behavior of fenofibrate was studied in various concentrations of (HPβCD) aq. solution at 37°C. The solubility of fenofibrate increased with an increase in the amount of HPβCD aq. solution. Gibbs free energy (ΔG°)tr values were all negative. Complexes of fenofibrate with HPβCD were prepared in 1:1 ratio by kneading and coprecipitation. These complexes were evaluated by dissolution studies, fourier transform infrared (FTIR) spectroscopy, and differential scanning calorimetry (DSC) studies.
RESULTS: The complexation of fenofibrate with HPβCD exhibited an enhanced dissolution rate. The mean dissolution time of fenofibrate decreased significantly upon complexation. FTIR studies showed the formation of intermolecular hydrogen bonding between fenofibrate and HPβCD. DSC studies indicated a loss in crystalline state of fenofibrate in complexes.
CONCLUSION: Complexation with HPβCD can be used as a useful tool for the enhancement of dissolution of fenofibrate. ©Copyright 2019 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  Fenofibrate; Gibbs free energy; dissolution rate; hydroxy propyl β-cyclodextrin; solubility

Year:  2018        PMID: 32454695      PMCID: PMC7227978          DOI: 10.4274/tjps.60490

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  16 in total

1.  Cyclodextrin Drug Carrier Systems.

Authors:  Kaneto Uekama; Fumitoshi Hirayama; Tetsumi Irie
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

2.  Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins.

Authors:  Hiroki Hamada; Kohji Ishihara; Noriyoshi Masuoka; Katsuhiko Mikuni; Nobuyoshi Nakajima
Journal:  J Biosci Bioeng       Date:  2006-10       Impact factor: 2.894

Review 3.  Micellar solubilization of drugs.

Authors:  Carlota Oliveira Rangel-Yagui; Adalberto Pessoa; Leoberto Costa Tavares
Journal:  J Pharm Pharm Sci       Date:  2005-07-08       Impact factor: 2.327

4.  Role of surfactant and pH on dissolution properties of fenofibrate and glipizide--a technical note.

Authors:  Shahla Jamzad; Reza Fassihi
Journal:  AAPS PharmSciTech       Date:  2006-04-07       Impact factor: 3.246

Review 5.  Prodrug strategies to overcome poor water solubility.

Authors:  Valentino J Stella; Kwame W Nti-Addae
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

Review 6.  Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

Authors:  N Blagden; M de Matas; P T Gavan; P York
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

7.  Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.

Authors:  Longxiao Liu; Suyan Zhu
Journal:  J Pharm Biomed Anal       Date:  2005-08-10       Impact factor: 3.935

Review 8.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.

Authors:  T Loftsson; M E Brewster
Journal:  J Pharm Sci       Date:  1996-10       Impact factor: 3.534

Review 9.  Cyclodextrins in topical drug formulations: theory and practice.

Authors:  T Loftsson; M Masson
Journal:  Int J Pharm       Date:  2001-08-28       Impact factor: 5.875

10.  Improvement of water solubility of non-competitive AMPA receptor antagonists by complexation with beta-cyclodextrin.

Authors:  Rosanna Stancanelli; Vincenza Crupi; Laura De Luca; Paola Ficarra; Rita Ficarra; Rosaria Gitto; Marta Guardo; Nunzio Iraci; Domenico Majolino; Silvana Tommasini; Valentina Venuti
Journal:  Bioorg Med Chem       Date:  2008-08-05       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.